337 related articles for article (PubMed ID: 31541663)
1. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers.
Barbosa JAC; Al-Kauraishi MM; Smith AM; Conway BR; Merchant HA
Eur J Pharm Biopharm; 2019 Nov; 144():174-179. PubMed ID: 31541663
[TBL] [Abstract][Full Text] [Related]
2. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
Patel MM; Amin AF
Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
[TBL] [Abstract][Full Text] [Related]
4. Sustained release enteric coated tablets of pantoprazole: formulation, in vitro and in vivo evaluation.
Wilson B; Babubhai PP; Sajeev MS; Jenita JL; Priyadarshini SR
Acta Pharm; 2013 Mar; 63(1):131-40. PubMed ID: 23482318
[TBL] [Abstract][Full Text] [Related]
5. Formulation parameters affecting the performance of coated gelatin capsules with pulsatile release profiles.
Bussemer T; Bodmeier R
Int J Pharm; 2003 Nov; 267(1-2):59-68. PubMed ID: 14602384
[TBL] [Abstract][Full Text] [Related]
6. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
Khan MZ; Prebeg Z; Kurjaković N
J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a food-based enteric coating for capsules and its compatibility with an alternative sealing method.
Caillard R; Blais JS; Akinocho G; Jacques W
Int J Pharm; 2016 Feb; 499(1-2):321-329. PubMed ID: 26773598
[TBL] [Abstract][Full Text] [Related]
8. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
Wu Y; Zhao F; Paborji M
Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
[TBL] [Abstract][Full Text] [Related]
9. Predicting the gastrointestinal behaviour of modified-release products: utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers.
Merchant HA; Goyanes A; Parashar N; Basit AW
Int J Pharm; 2014 Nov; 475(1-2):585-91. PubMed ID: 25195730
[TBL] [Abstract][Full Text] [Related]
10. Industrial Manufacture of Enteric Hard Capsules Using Novel Formulations Based on Hypromellose Phthalate/Gelatin and Investigation of Pantoprazole Release.
Kalmer RR; Haddadan MM; Azizi M; Ghanbari M; Samandarian D; Sadjadinia A; Ramezanalizadeh H; Karimi A; Golizadeh M
ACS Omega; 2023 Mar; 8(12):11293-11303. PubMed ID: 37008088
[TBL] [Abstract][Full Text] [Related]
11. Formulation and development of gastroretentive drug delivery system for ofloxacin.
Ali J; Hasan S; Ali M
Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):433-9. PubMed ID: 17003848
[TBL] [Abstract][Full Text] [Related]
12. Blend of cellulose ester and enteric polymers for delayed and enteric coating of core tablets of hydrophilic and hydrophobic drugs.
Ali SFB; Afrooz H; Hampel R; Mohamed EM; Bhattacharya R; Cook P; Khan MA; Rahman Z
Int J Pharm; 2019 Aug; 567():118462. PubMed ID: 31247274
[TBL] [Abstract][Full Text] [Related]
13. Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device.
McConville JT; Ross AC; Florence AJ; Stevens HN
Drug Dev Ind Pharm; 2005 Jan; 31(1):79-89. PubMed ID: 15704859
[TBL] [Abstract][Full Text] [Related]
14. HPMC capsules: current status and future prospects.
Al-Tabakha MM
J Pharm Pharm Sci; 2010; 13(3):428-42. PubMed ID: 21092714
[TBL] [Abstract][Full Text] [Related]
15. Enteric polymers as acidifiers for the pH-independent sustained delivery of a weakly basic drug salt from coated pellets.
Körber M; Ciper M; Hoffart V; Pearnchob N; Walther M; Macrae RJ; Bodmeier R
Eur J Pharm Biopharm; 2011 Aug; 78(3):447-54. PubMed ID: 21443950
[TBL] [Abstract][Full Text] [Related]
16. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
Varum FJ; Hatton GB; Freire AC; Basit AW
Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
[TBL] [Abstract][Full Text] [Related]
17. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
[TBL] [Abstract][Full Text] [Related]
18. Coated hard capsules as the pH-dependent drug transport systems to ileo-colonic compartment.
Dvořáčková K; Rabišková M; Muselík J; Gajdziok J; Bajerová M
Drug Dev Ind Pharm; 2011 Oct; 37(10):1131-40. PubMed ID: 21417619
[TBL] [Abstract][Full Text] [Related]
19. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.
Gohel MC; Sumitra G M
J Control Release; 2002 Feb; 79(1-3):157-64. PubMed ID: 11853927
[TBL] [Abstract][Full Text] [Related]
20. Erodible time-dependent colon delivery systems with improved efficiency in delaying the onset of drug release.
Del Curto MD; Palugan L; Foppoli A; Zema L; Gazzaniga A; Maroni A
J Pharm Sci; 2014 Nov; 103(11):3585-3593. PubMed ID: 25213173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
